These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10023899)

  • 1. Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies.
    Farquhar C; Dickinson A; Bruce M
    Lancet; 1999 Jan; 353(9147):117. PubMed ID: 10023899
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
    Todd NV; Morrow J; Doh-ura K; Dealler S; O'Hare S; Farling P; Duddy M; Rainov NG
    J Infect; 2005 Jun; 50(5):394-6. PubMed ID: 15907546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease.
    Whittle IR; Knight RS; Will RG
    Acta Neurochir (Wien); 2006 Jun; 148(6):677-9; discussion 679. PubMed ID: 16598408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?
    Rainov NG; Tsuboi Y; Krolak-Salmon P; Vighetto A; Doh-Ura K
    Expert Opin Biol Ther; 2007 May; 7(5):713-26. PubMed ID: 17477808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
    Parry A; Baker I; Stacey R; Wimalaratna S
    J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):733-4. PubMed ID: 17314188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antiscrapie effect using combination drug treatment.
    Kocisko DA; Caughey B; Morrey JD; Race RE
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3447-9. PubMed ID: 17005828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New knowledge about Creutzfeldt-Jakob disease can yield therapeutic possibilities].
    Stølsmark T; Tysnes OB
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):601-4. PubMed ID: 20349004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system. An experimental animal study.
    Marsh NA; Gaffney PJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):255-61. PubMed ID: 2427408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Less protease-resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate.
    Terada T; Tsuboi Y; Obi T; Doh-ura K; Murayama S; Kitamoto T; Yamada T; Mizoguchi K
    Acta Neurol Scand; 2010 Feb; 121(2):127-30. PubMed ID: 19804470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental treatment may show promise for vCJD.
    Pincock S
    Lancet; 2003 Oct; 362(9390):1130. PubMed ID: 14558510
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentosan in transmissible spongiform encephalopathies.
    Deli MA; Niwa M; Katamine S; Abrahám CS
    Lancet; 1999 Apr; 353(9160):1272. PubMed ID: 10217107
    [No Abstract]   [Full Text] [Related]  

  • 13. Family finds hospital willing to give experimental CJD treatment.
    Dyer O
    BMJ; 2003 Jan; 326(7379):8. PubMed ID: 12511437
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system--a human volunteer and experimental animal study.
    Marsh NA; Peyser PM; Creighton LJ; Mahmoud M; Gaffney PJ
    Thromb Haemost; 1985 Dec; 54(4):833-7. PubMed ID: 2418527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic studies with 3H-pentosan polysulphate in rabbits.
    Richter M; Klöcking HP; Markwardt F
    Pharmazie; 1987 Oct; 42(10):699-700. PubMed ID: 2449700
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models.
    Doh-ura K; Ishikawa K; Murakami-Kubo I; Sasaki K; Mohri S; Race R; Iwaki T
    J Virol; 2004 May; 78(10):4999-5006. PubMed ID: 15113880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease: hopes for therapy.
    Pocchiari M; Ladogana A; Graziano S; Puopolo M
    Eur J Neurol; 2008 May; 15(5):435-6. PubMed ID: 18394045
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoprophylaxis of scrapie in mice.
    Diringer H; Ehlers B
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():457-60. PubMed ID: 1704414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bovine spongiform encephalopathy and natural scrapie].
    Fontaine JJ
    C R Seances Soc Biol Fil; 1997; 191(5-6):731-53. PubMed ID: 9587482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.
    Gregori L; McCombie N; Palmer D; Birch P; Sowemimo-Coker SO; Giulivi A; Rohwer RG
    Lancet; 2004 Aug 7-13; 364(9433):529-31. PubMed ID: 15302197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.